21022 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof Oxidoreductases (1)
METHOD OF ATTACHING A CELL-OF-INTEREST TO A MICROTUBE
#302Pharmaceutical preparations and methods to manage weight and to modulate the gut microbiota
#303Recombinant uricase enzyme
#304STABLE EXPRESSION OF AAV VECTORS IN JUVENILE SUBJECTS
#305Methods and products for nucleic acid production and delivery
#306METHODS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS WITH ENHANCED PHARMACOLOGICAL PROPERTIES
#307COMPOSITION FOR WOUND HEALING
#308Modified polynucleotides for the production of secreted proteins
#309METHODS AND COMPOSITIONS COMPRISING VIRAL GENE THERAPY AND AN IMMUNE CHECKPOINT INHIBITOR FOR TREATMENT AND PREVENTION OF CANCER AND INFECTIOUS DISEASES
#310Engineering the RRM2 subunit of ribonucleotide reductase to resist degradation
#311REDUCTION OF LIPASE ACTIVITY IN PRODUCT FORMULATIONS
#312Nucleic acid constructs and methods of using the same
#313Bioresponsive particles
#314Compositions and methods for disrupting biofilm formation and maintenance
#315Core-shell microneedle devices and uses thereof
#316MODULATION OF ISCHEMIC CELL BIOENERGETICS
#317Expression vector for cholesterol 24-hydrolase in therapy of polyglutamine repeat spinocerebellar ataxias
#318Inhibiting the onset of gout
#319Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
#320Variant forms of urate oxidase and use thereof
#321Modified polynucleotides for the production of secreted proteins
#322METHOD OF PRODUCING PHYSIOLOGICAL AND THERAPEUTIC LEVELS OF NITRIC OXIDE THROUGH AN ORAL DELIVERY SYSTEM
#323COMPOSITIONS AND USES THEREOF
#324Agent for use in the case of fructose intolerance
#325Methods for diagnosing IDH-mutant cell proliferation disorders
#326Multimeric coding nucleic acid and uses thereof
#327COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#328Method for visually enhancing the experience of an audience during a performance
#329COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF COLITIS IN INFANTS
#330Composition comprising pollen and/or pistil extracts, preparation process and associated uses
#331mRNA therapy for phenylketonuria
#332Bioactive nanoparticles and methods for making same
#333Immunostimulant
#334Lipid-derived neutral nanoparticles
#335Myeloperoxidase compositions and methods for inhibition of lipopolysaccharides and lipid A
#336Methods and compositions related to physiologically responsive microneedle delivery systems
#337Enzyme and application thereof
#338Combination, therapeutic uses and prophylactic uses
#339Amphipathic peptide
#340METHODS OF TREATING CANCER OF THE CENTRAL NERVOUS SYSTEM
#341Compositions and methods for treating or preventing oxalate-related disease
#342ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS
#343NEURONAL VIABILITY FACTOR AND USE THEREOF
#344Abuse-deterrent pharmaceutical composition
#345Oral lipid supplements for treating pain and fibromyalgia
#346Chemotactic, drug-containing polymersomes
#347Inhibiting UVB-Irradiation Damage By Targeting Nitric Oxide Synthases (cNOS)
#348Compositions and methods for detecting, treating and preventing diseases and disorders
#349Composition for uric acid decomposition using gold nanoparticles
#350Mutant glyceraldehyde-3-phosphate dehydrogenase (GAPDH) compositions and methods of treating cancer
#351Compositions and methods for treating or preventing diseases associated with oxidative stress
#352NICOTINE-DEGRADING ENZYMES FOR TREATING NICOTINE ADDICTION AND NICOTINE POISONING
#353Ophthalmic treatment device, system, and method of use
#354Ophthalmic treatment device, system, and method of use
#355INHIBITING OR INACTIVATING THE VIRULENCE OF A LIVE PATHOGEN
#356Methods and compositions for treatment of ocular disorders and blinding diseases
#357CELL TRANSPLANTATION DEVICE
#358High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate
#359Compositions derived from Cohn fraction paste and use thereof
#360METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE
#361CYP-P22 biocatalytic nanoparticles with cytochrome P450 activity for prodrug activation
#362Treating glaucoma, cardiovascular diseases, and renal diseases
#363METHODS AND COMPOSITIONS FOR TREATMENT OF MITOCHONDRIAL DISORDERS
#364Compositions and methods for the treatment of cancer
#365Compositions and methods for regulating activity of inhibitor of DNA binding-2 (ID2) protein and for treating ID protein-related diseases
#366Composition comprising an oxidoreductase enzyme and its antibacterial use
#367COMPOSITIONS FOR PROTEIN DELIVERY AND METHODS OF USE THEREOF
#368METHODS AND COMPOSITIONS FOR TREATING DISEASES
#369Recombinant high-stability superoxide dismutase and application thereof
#370Methods and compositions related to combined treatment with antiinflammatories and synthetic nanocarriers comprising an immunosuppressant
#371Diagnosis and treatment of preeclampsia
#372COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#373METHODS AND PRODUCTS FOR NUCLEIC ACID PRODUCTION AND DELIVERY
#374Methods of diagnosis and treatment involving nitrite
#375RNA preparations comprising purified modified RNA for reprogramming cells
#376Block copolymers
#377Saposin B binds the lipofuscin bisretinoid A2E and prevents its enzymatic and photo degradation
#378THIOREDOXIN, THIOREDOXIN PEPTIDES OR DERIVATIVES FOR TREATMENT OF AGE-RELATED HYPERTENSION
#379NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE
#380Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy
#381Reduction of lipase activity in product formulations
#382MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF NUCLEAR PROTEINS
#383Agent for use in the case of fructose intolerance
#384Lipid-derived neutral nanoparticles
#385Lipid-derived neutral nanoparticles
#386Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system
#387Process of Preparing mRNA-Loaded Lipid Nanoparticles
#388Methods and compositions to modulate the gut microbiota and to manage weight
#389ORAL DELIVERY SYSTEM FOR BIOACTIVE AGENTS
#390DRUG-DELIVERING COMPOSITE STRUCTURES
#391DLDH, DERIVATIVES THEREOF AND FORMULATIONS COMPRISING SAME FOR USE IN MEDICINE
#392Vectors and methods for regenerative therapy
#393ORAL CARE COMPOSITION
#394CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE
#395Glucose-responsive insulin delivery microneedle system
#396MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE
#397Targeted therapeutic proteins
#398Amphipathic peptide
#399COMPOSITIONS AND METHODS OF ALTERING CHOLESTEROL LEVELS
#400Method for utilizing engineered dendritic cells to induce gut-homing regulatory T cells and treat gut inflammation
#401Methods and products for nucleic acid production and delivery
#402Regulation of gene expression by aptamer-mediated modulation of alternative splicing
#403Vectors conditionally expressing therapeutic proteins, host cells comprising the vectors, and uses thereof
#404Modified polynucleotides for the production of oncology-related proteins and peptides
#405Polypeptides Having N-Acetyl Glucosamine Oxidase Activity
#406Co-encapsulation of live cells with oxygen-generating particles
#407Pharmaceuticals and methods for treating hypoxia and screening methods therefor
#408Protein material
#409Selective Nox-1 inhibitor peptides and uses thereof
#410Variant forms of urate oxidase and use thereof
#411AGENT FOR USE IN THE CASE OF FRUCTOSE INTOLERANCE
#412Chewable lipid supplements for treating pain and fibromyalgia
#413Multimeric coding nucleic acid and uses thereof
#414Variant forms of urate oxidase and use thereof
#415Variant forms of urate oxidase and use thereof
#416VARIANT FORMS OF URATE OXIDASE AND USE THEREOF
#417VARIANT FORMS OF URATE OXIDASE AND USE THEREOF
#418Beverage, and method of producing the same
#419Compositions and methods for treating thyroid disease
#420Compositions and methods for the treatment of photoaging and other conditions
#421Phenazine degrading agents and related compositions, methods and systems for interfering with viability of bacteria
#422Synthetically functionalized living cells for targeted drug delivery
#423Functions of 55 Newfound Proteins and Their Medicinal Application in the Treatment and Prevention of Disease
#424FORMULATIONS AND DOSES OF PEGYLATED URICASE
#425Compositions and Methods of Using Interleukin-4 Induced Gene 1 (IL-4I1)
#426Polymer conjugates having reduced antigenicity and methods of using the same
#427Protein/oligonucleotide core-shell nanoparticle therapeutics
#428BACTERIA ENGINEERED TO TREAT DISORDERS INVOLVING THE CATABOLISM OF A BRANCHED CHAIN AMINO ACID
#429FUNCTIONAL FOODS COMPRISING DIAMINE OXIDASE AND USES THEREOF
#430METHODS AND COMPOSITIONS FOR TREATMENT OF MITOCHONDRIAL DISORDERS
#431Substituted benzo[f]imidazo[1,2-a]quinoxalines
#432PREPARATION FOR FORMING EMBOLI AND MICROCATHETER
#433Stabilization of Aqueous Compositions of Proteins With Displacement Buffers
#434Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#435MATERIALS AND METHODS FOR TREATING DISORDERS ASSOCIATED WITH SULFATASE ENZYMES
#436POLYMER CONJUGATES WITH DECREASED ANTIGENICITY, METHODS OF PREPARATION AND USES THEREOF
#437Use of microperoxidases for the treatment of carboxyhemoglobinemia
#438Thioredoxin or Thioredoxin Derivatives or Peptides for the Treatment of High Blood Pressure
#439Use of Hydrolytic and Oxidative Enzymes to Dissolve Biofilm in Ears
#440Co-encapsulation of live cells with oxygen-generating particles
#441ENZYMATIC SYNTHESIS OF POLY(AMINE-CO-ESTERS) AND METHODS OF USE THEREOF FOR GENE DELIVERY
#442GENE EXPRESSION SYSTEM AND REGULATION THEREOF
#443Methods and compositions for treating phenylketonuria
#444NITRIC OXIDE-MODULATING BONE-TARGETING COMPLEXES
#445Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, immunoglobulins and chemotactic factors
#446MRNA therapy for phenylketonuria
#447Compositions and methods for treating or preventing diseases associated with oxidative stress
#448Ophthalmic treatment device, system, and method of use
#449DRUG-DELIVERING COMPOSITE STRUCTURES
#450COMPLEXING AGENTS FOR COMPOSITIONS CONTAINING INCLUSION COMPLEXES
#451Method for treating cell proliferation related disorders
#452Use of multi-arm polyethylene glycol modifier and application of multi-arm polyethylene glycol modifier in L-asparaginasum modification
#453METHODS OF USING CYCLOOXYGENASE-PROSTACYCLIN SYNTHASE FUSION GENE
#454Methods of treatment using recombinant oxalate oxidase
#455MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF NUCLEAR PROTEINS
#456Chewable lipid supplements containing caffeine for increasing alertness, focus and energy
#457Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome
#458Treatment of proliferative disorders with a chemiluminescent agent
#459Polymer particles and uses thereof
#460METHODS OF ATTACHING A MOLECULE-OF-INTEREST TO A MICROTUBE
#461MOLECULE ASSOCIATED WITH ONSET OF GOUT, AND METHOD AND KIT FOR EVALUATING DIATHESIS OF URIC ACID-RELATED DISEASES AND INFLAMMATION-RELATED DISEASES, AND INSPECTION OBJECT AND DRUG
#462METHODS AND KITS FOR PREDICTING INFUSION REACTION RISK AND ANTIBODY-MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPY
#463Modified polynucleotides for the production of secreted proteins
#464TOPICAL COMPOSITION COMPRISING NATURAL INGREDIENTS FOR BRUISING OR HEMATOMA HEALING ON SKIN AND USE THEREOF
#465RNA preparations comprising purified modified RNA for reprogramming cells
#466DIAGNOSIS AND TREATMENT OF MULTIPLE SULFATASE DEFICIENCY AND OTHER SULFATASE DEFICIENCIES
#467Cell penetrating protein adaptor molecules and their application in research and medicine
#468Modulation of tissue transglutaminase activation in disease
#469Nitric oxide synthase nanoparticles for treatment of vascular disease
#470Methods and products for nucleic acid production and delivery
#471Reduction of lipase activity in product formulations
#472Methods and compositions for treating diseases
#473CARTILAGE REGENERATION-PROMOTING AGENT
#474Synergistic glycocalyx treatment compositions and methods
#475Treating glaucoma, cardiovascular diseases, and renal diseases
#476Treatment for cancer
#477Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system
#478Methods and Compositions for the Treatment of Vaginal Diseases Employing Peroxide-Producing Enzymes and Peroxidases
#479Compositions and methods for enzymatic treatment of lung disorders
#480Methods for treating hepatitis C virus infectious disease
#481INCLUSION BODIES FOR TRANSDERMAL DELIVERY OF THERAPEUTIC AND COSMETIC AGENTS
#482COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF METABOLIC STEATOSIS AND STEATOHEPATITIS
#483Modified RNA with decreased immunostimulatory properties
#484Pharmaceutical composition for preventing and treating cancer, containing CYB5R3 gene or protein as active ingredient
#485PRODUCT AND PROCESS FOR MUCUS VISCOSITY NORMALIZATION
#486PROTEINS FOR TARGETING NEURONAL NITRIC OXIDE SYNTHASE TO MUSCLE SARCOLEMMA AND RELATED METHODS OF USE
#487Block copolymers
#488Designed peptides for tight junction barrier modulation
#489PROLAMIN-BASED FILM AND METHOD FOR MANUFACTURING PROLAMIN-BASED ORAL FILM FOR PROTECTING ACTIVITY OF ANTI-OXIDATIVE MATERIAL
#490Compositions and methods for the treatment of cancer
#491Composition containing polycationic triblock copolymer, polyanionic polymer and physiologically active peptide
#492SYNTHESIS METHOD FOR L-HETEROCYCLIC AMINO ACID AND PHARMACEUTICAL COMPOSITION HAVING THEREOF
#493Targeted therapeutic proteins
#494Compositions, methods, and devices for dialysis
#495Use of hydrolytic and oxidative enzymes to dissolve biofilm in airway passages
#496Compositions and Methods of Altering Cholesterol Levels
#497COMPOSITION OF ERYTHROCYTES ENCAPSULATING PHENYLALANINE HYDROXYLASE AND THERAPEUTIC USE THEREOF
#498Methods and compositions for delivering active agents with enhanced pharmacological properties
#499Enzyme formulation for use as food supplement
#500HYBRID PROTEIN THAT CONVERTS ARACHIDONIC ACID INTO PROSTACYCLIN
#501Vectors encoding rod-derived cone viability factor
#502Immunity induction agent
#503QSOX1 as an anti-neoplastic drug target
#504METHOD FOR INACTIVATING A PRION PROTEIN
#505Development of Protein-Based Biotherapeutics That Penetrate Cell-Membrane and Induce Anti-Cancer Effect- Cell-Permeable Glutathione Peroxidase7 (CP-GPX7) in Gastrointestinal Track (GIT), Polynucleotides Encoding the Same, and Anti-Cancer Compositions Comprising the Same
#506Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
#507Frataxin mutants
#508Animal feed enzymes
#509Milk basic protein composition and production process therefor
#510Method of deriving mature hepatocytes from human embryonic stem cells
#511METHODS OF DIAGNOSING AND TREATING FIBROSIS
#512TOPICAL COMPOSITIONS COMPRISING DIAMINOOXIDASE FOR THE TREATMENT OR PREVENTION OF DISEASES ASSOCIATED WITH HIGH HISTAMINE LEVELS WHICH INVOLVE AN INCREASE IN PAIN
#513Sensation-improving agent
#514ASSAY METHOD
#515Method of altering vascular permeability and uses thereof
#516Methods of treating spinal cord injury
#517Milk-derived basic protein fraction as skin sensitivity improving agent
#518Modified polynucleotides for the production of secreted proteins
#519Use of human biliverdin reductase and fragments thereof for the treatment of protein kinase C-delta and ERK related conditions
#520TREATMENT OF SKIN DISORDERS
#521Treatment of bone diseases
#522BEVERAGE, AND METHOD OF PRODUCING THE SAME
#523Cheese and method for producing the same
#524Therapeutic compounds and methods
#525Flavored chewable lipid supplements for maintaining health and the treatment of acute and chronic disorders
#526Amphipathic peptide
#527Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy due to Friedreich ataxia
#528Restoring phosphorylation of a novel PINK1 substrate to treat parkinson's disease
#529NOVEL PROTEIN MATERIAL
#530Method of treating cancer using high efficiency self-illuminative nanocomplexes and method of manufacturing the same
#531METHOD OF ENHANCING GLUCOSE-STIMULATED INSULIN SECRETION AND OF TREATING TYPE 2 DIABETES OR HYPOGLYCEMIA
#532Combination treatment for amyotrophic lateral sclerosis (ALS)
#533SYSTEM AND METHOD FOR DETECTING CANCER
#534METHODS FOR ALLEVIATING SYMPTOMS OF MULTIPLE SCLEROSIS BASED ON APOAEQUORIN-CONTAINING COMPOSITIONS
#535Substituted benzo[f]imidazo[1,2-a]quinoxalines and imidazo[1,2-a]pyrazines
#536Drug delivery composition comprising proteins and biodegradable polyesteramides
#537Methods of treating cancer of the central nervous system
#538CYTOCHROME P450 SUICIDE GENE SYSTEM
#539Compositions and methods for detecting, treating and preventing diseases and disorders
#540Method for preparing a bone protein preparation and a bone protein preparation
#541COMPOSITIONS AND METHODS FOR TREATMENT OF VITILIGO
#542Variant forms of urate oxidase and use thereof
#543Bioactive heme-haloperoxidase compositions and methods of their use
#544Compositions and methods for treating or preventing diseases associated with oxidative stress
#545Compositions and methods for gene therapy
#546Mycotoxin-reducing composition
#547Deactivation of urushiol and method of treatment and prevention of contact dermatitis
#548CARTILAGE REGENERATION-PROMOTING AGENT
#549Composition for treating headaches
#550Method and composition for oral health care treatment
#551Ocular cross-linking system and method for sealing corneal wounds
#552Compositions and methods for oxalate reduction
#553Pharmaceutical composition containing human cyclooxygenase and doxorubicin or doxorubicin analogue, preparation method therefor and use thereof in preparing drugs
#554MRNA therapy for phenylketonuria
#555COMPOSITIONS AND METHODS FOR TREATMENT OF VITILIGO
#556Diamine oxidase for use in the treatment or prevention of attention deficit hyperactivity disorder (ADHD)
#557Lipid-derived neutral nanoparticles
#558Stabilization of Aqueous Compositions of Proteins with Displacement Buffers
#559Product and process for liquefaction of mucus or sputum
#560Treating glaucoma, cardiovascular diseases, and renal diseases
#561COMPLEXING AGENTS FOR COMPOSITIONS CONTAINING INCLUSION COMPLEXES
#562Glucose-responsive microgels for closed loop insulin delivery
#563COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#564Method of identifying a compound for treating a hypoxic or ischemic related disorder
#565Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, and chemotactic factors
#566Method of reducing levels of uric acid
#567PROTOCOLS FOR TREATING AND PREVENTING OBESITY AND COMPLICATIONS ARISING THEREFROM
#568Stable aqueous suspension
#569Vectors encoding rod-derived cone viability factor
#570Co-encapsulation of live cells with oxygen-generating particles
#571Use of Inclusion Bodies as Therapeutic Agents
#572METHOD FOR TREATMENT OR PREVENTION OF ALLERGIC DISEASES
#573Product and process for mucus viscosity normalization
#574Dissolution of Arterial Plaque
#575Diaminooxidase-containing pharmaceutical compositions
#576Oral enzyme compositions for intestinal delivery
#577Compositions and methods for the treatment of lysosomal storage disorders
#578PROTEIN-BASED STREPTOCOCCUS PNEUMONIAE VACCINES
#579Ophthalmic treatment device, system, and method of use
#580ORAL DELIVERY OF ENZYMES BY NANOCAPSULES FOR TARGETED METABOLISM OF ALCOHOL OR TOXIC METABOLITES
#581METHODS AND COMPOSITIONS FOR TREATMENT OF LESIONED SITES OF BODY VESSELS
#582Application of PRDX2 and/or PRDX6 in improving sperm quality or treating male infertility
#583QSOX1 as an Anti-Neoplastic Drug Target
#584TREATMENTS INVOLVING GLUTAREDOXINS AND SIMILAR AGENTS
#585Multiple-enzyme nanocomplexes
#586Treatment of microbial infections
#587Eosinophil peroxidase compositions and methods of their use
#588SILK MICROSPHERES FOR ENCAPSULATION AND CONTROLLED RELEASE
#589Compositions and methods for the treatment of cancer
#590Treatment method for microbial infection
#591Anti-allergic substance, anti-allergic agent, and food
#592Compositions and methods for treating or preventing oxalate-related disease
#593Modulation of cell fates and activities by phthalazinediones
#594Treatment of proliferative disorders with a chemiluminescent agent
#595TOPICAL COMPOSITIONS COMPRISING DIAMINOOXIDASE FOR THE TREATMENT OR PREVENTION OF DISEASES ASSOCIATED WITH HIGH HISTAMINE LEVELS WHICH INVOLVE AN INCREASE IN PAIN
#596COMPOSITION COMPRISING DIAMINE OXIDASE FOR USE IN THE TREATMENT OR PREVENTION OF FIBROMYALGIA OR CHRONIC FATIGUE SYNDROME
#597FUNCTIONAL FOODS COMPRISING DIAMINE OXIDASE AND USES THEREOF
#598COMPOSITION COMPRISING DIAMINE OXIDASE FOR THE PREVENTION OF HANGOVER SYMPTOMS
#599Methods of Modifying Insulin Signaling Using Biliverdin Reductase (BVR) and BVR Derived Peptides
#600MATERIAL COMBINATION FOR TREATING INFLAMMATORY OR INFECTIOUS DISEASES